Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuation study of tildrakizumab in adults with chronic moderate-to-severe plaque psoriasis after completion of study 0172-13
MOH_2021-02-25_009792Phase 4Not yet recruiting
- Sponsor
- דר' מיכל רמון
- Start
- Feb 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tildrakizumab in plaque psoriasis, sponsored by דר' מיכל רמון. Planned start Feb 2021; status: not yet recruiting.
02
Drugs
tildrakizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on MOH_2021-02-25_009792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-02-25_009792.